Elabela vs Intermedin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Elabela (also called Apela or Toddler) is the second endogenous peptide ligand for the APJ receptor, discovered in 2013 independently through two approaches: as an essential zebrafish cardiac development factor (Toddler) and as a novel human APJ ligand (Elabela). Unlike apelin pe...
Calculate Elabela dose →Intermedin (also called Adrenomedullin 2, AM2) is a 47-53 amino acid peptide belonging to the calcitonin gene-related peptide (CGRP)/adrenomedullin superfamily. Discovered in 2004, intermedin is widely expressed in the heart, lung, kidney, gut, and brain....
Calculate Intermedin dose →| Parameter | Elabela | Intermedin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Research | Preclinical Research |
| Half-Life | Short (minutes, estimated) | ~15-30 minutes |
| Typical Dose | 5-500 nmol/kg (animal) | 1-100 pmol/kg/min infusion (animal) |
| Frequency | Variable | Acute infusion |
| Route | Subcutaneous, Intravenous | IV (research); SC in some studies |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.